Filing Details
- Accession Number:
- 0001179110-11-014787
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-03 16:17:59
- Reporting Period:
- 2011-11-01
- Filing Date:
- 2011-11-03
- Accepted Time:
- 2011-11-03 16:17:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Corp & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-01 | 3,500 | $16.01 | 33,290 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-01 | 3,500 | $41.01 | 29,790 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-11-01 | 3,500 | $17.50 | 33,290 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-01 | 3,500 | $41.01 | 29,790 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-11-01 | 515 | $19.36 | 30,305 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-11-01 | 9,485 | $17.50 | 39,790 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-01 | 1,000 | $41.01 | 38,790 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-11-01 | 3,500 | $0.00 | 3,500 | $16.01 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-11-01 | 515 | $0.00 | 515 | $19.36 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-11-01 | 3,500 | $0.00 | 3,500 | $17.50 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-11-01 | 9,485 | $0.00 | 9,485 | $17.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-26 | No | 4 | M | Direct | |
| 0 | 2015-05-09 | No | 4 | M | Direct | |
| 64,360 | 2013-07-29 | No | 4 | M | Direct | |
| 54,875 | 2013-07-29 | No | 4 | M | Direct |
Footnotes
- The options have a 5 year vesting schedule. 20% of the options vested on January 26, 2006, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 26, 2010. The options expire on January 26, 2015.
- The options have a 5 year vesting schedule. 20% of the options vested on May 9, 2006, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on May 9, 2010. The options expire on May 9, 2015.
- The options have a 5 year vesting schedule. 20% of the options vested on July 30, 2004, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on July 30, 2008. The options expire on July 29, 2013.
- Sale prices reported for the transaction reported here range from $40.70 to $41.2701. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
- Pursuant to a Rule 105b-1 trading plan established by Mr. Alton on August 19, 2009 and amended July 30, 2010
Billionaire Hedge Funds
